{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T06:03:50Z","timestamp":1780293830772,"version":"3.54.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04812-7","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:36:51Z","timestamp":1780292211000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Validity of a seven-gene signature as a non-invasive biomarker for cirrhosis: a cross-sectional study in Egyptian patients with HBV infection"],"prefix":"10.1186","volume":"26","author":[{"given":"Ahlam Abd","family":"El-Kader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai Abd","family":"El-Meguid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naglaa","family":"Zayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen Abdel","family":"Alem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Barkat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reham M.","family":"Dawood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"issue":"2","key":"4812_CR1","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3390\/v13020245","volume":"13","author":"PP Mathkar","year":"2021","unstructured":"Mathkar PP, Chen X, Sulovari A, Li D. Characterization of hepatitis B virus integrations identified in hepatocellular carcinoma genomes. Viruses. 2021;13(2):245.","journal-title":"Viruses"},{"key":"4812_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s15010-019-01345-y","volume":"48","author":"E Sagnelli","year":"2020","unstructured":"Sagnelli E, Macera M, Russo A, Coppola N, Sagnelli C. Epidemiological and etiological variations in hepatocellular carcinoma. Infection. 2020;48:7\u201317.","journal-title":"Infection"},{"issue":"11","key":"4812_CR3","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1136\/gutjnl-2019-319637","volume":"69","author":"D Salerno","year":"2020","unstructured":"Salerno D, Chiodo L, Alfano V, Floriot O, Cottone G, Paturel A, et al. Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription. Gut. 2020;69(11):2016\u201324.","journal-title":"Gut"},{"key":"4812_CR4","doi-asserted-by":"crossref","unstructured":"Al-Busafi SA, Alwassief A. Global Perspectives on the Hepatitis B Vaccination: Challenges, Achievements, and the Road to Elimination by 2030. Vaccines (Basel). 2024;12(3).","DOI":"10.3390\/vaccines12030288"},{"issue":"10","key":"4812_CR5","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S2468-1253(23)00197-8","volume":"8","author":"D Razavi-Shearer","year":"2023","unstructured":"Razavi-Shearer D, Gamkrelidze I, Pan C, Jia J, Berg T, Gray R, et al. Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study. Lancet Gastroenterol Hepatol. 2023;8(10):879\u2013907.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"4812_CR6","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3389\/fgene.2019.00696","volume":"10","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Wang C, Liu Z, Zou G, Li J, Lu M. Host genetic determinants of hepatitis B virus infection. Front Genet. 2019;10:696.","journal-title":"Front Genet"},{"key":"4812_CR7","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.meegid.2017.08.011","volume":"66","author":"JH Ellwanger","year":"2018","unstructured":"Ellwanger JH, de Lima Kaminski V, Valverde-Villegas JM, Simon D, Lunge VR, Chies JAB. Immunogenetic studies of the hepatitis C virus infection in an era of pan-genotype antiviral therapies-Effective treatment is coming. Infect Genet Evol. 2018;66:376\u201391.","journal-title":"Infect Genet Evol"},{"issue":"8","key":"4812_CR8","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41575-023-00760-9","volume":"20","author":"Y-C Hsu","year":"2023","unstructured":"Hsu Y-C, Huang DQ, Nguyen MH. Global burden of hepatitis B virus: current status, missed opportunities and a call for action. Nat Reviews Gastroenterol Hepatol. 2023;20(8):524\u201337.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"issue":"5","key":"4812_CR9","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/ng.348","volume":"41","author":"Y Kamatani","year":"2009","unstructured":"Kamatani Y, Wattanapokayakit S, Ochi H, Kawaguchi T, Takahashi A, Hosono N, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat Genet. 2009;41(5):591\u20135.","journal-title":"Nat Genet"},{"issue":"2","key":"4812_CR10","doi-asserted-by":"publisher","first-page":"117105","DOI":"10.1016\/j.diagmicrobio.2025.117105","volume":"114","author":"MA El-Meguid","year":"2026","unstructured":"El-Meguid MA, Salum GM, Fotouh BE, Zayed N, Alem SA, Yosry A, et al. Evaluation of PNPLA3 genetic variants in Egyptian HBV-infected patients concomitant with metabolic-associated steatotic liver disease (MASLD). Diagn Microbiol Infect Dis. 2026;114(2):117105.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"4812_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/hep.21695","volume":"46","author":"H Huang","year":"2007","unstructured":"Huang H, Shiffman ML, Friedman S, Venkatesh R, Bzowej N, Abar OT, et al. A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Hepatology. 2007;46(2):297\u2013306.","journal-title":"Hepatology"},{"key":"4812_CR12","doi-asserted-by":"publisher","first-page":"104805","DOI":"10.1016\/j.micpath.2021.104805","volume":"153","author":"RM Dawood","year":"2021","unstructured":"Dawood RM, Salum GM, El-Meguid MA, Elsayed A, Yosry A, Abdelaziz A, et al. Development of a gene signature for predicting cirrhosis risk score of chronic liver disease associated with HCV infection in Egyptians. Microb Pathog. 2021;153:104805.","journal-title":"Microb Pathog"},{"issue":"1","key":"4812_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s43141-021-00266-4","volume":"19","author":"GM Salum","year":"2021","unstructured":"Salum GM, El Meguid MA, Abelhafez TH, Medhat E, Abdel Aziz AO, Dawood R. Evaluation of seven gene signature for predicting HCV recurrence post-liver transplantation. J Genet Eng Biotechnol. 2021;19(1):174.","journal-title":"J Genet Eng Biotechnol"},{"issue":"3","key":"4812_CR14","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","volume":"75","author":"A Berzigotti","year":"2021","unstructured":"Berzigotti A, Tsochatzis E, Boursier J, Castera L, Cazzagon N, Friedrich-Rust M, et al. EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2013 2021 update. J Hepatol. 2021;75(3):659\u201389.","journal-title":"J Hepatol"},{"issue":"6","key":"4812_CR15","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43(6):1317\u201325.","journal-title":"Hepatology"},{"issue":"2","key":"4812_CR16","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","volume":"38","author":"C-T Wai","year":"2003","unstructured":"Wai C-T, Greenson JK, Fontana RJ, Kalbfleisch JD, Marrero JA, Conjeevaram HS, et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology. 2003;38(2):518\u201326.","journal-title":"Hepatology"},{"issue":"5","key":"4812_CR17","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1089\/dna.2020.5402","volume":"39","author":"JT Blitzer","year":"2020","unstructured":"Blitzer JT, Wang L, Summers SA. DES1: A Key Driver of Lipotoxicity in Metabolic Disease. DNA Cell Biol. 2020;39(5):733\u20137.","journal-title":"DNA Cell Biol"},{"issue":"1","key":"4812_CR18","doi-asserted-by":"publisher","first-page":"31","DOI":"10.5536\/KJPS.2019.46.1.31","volume":"46","author":"J-D Oh","year":"2019","unstructured":"Oh J-D, Bigirwa G, Lee S, Song K-D. Molecular Characterization and Expression Analysis of Clathrin-Associated Adaptor Protein 3-\u03b4 Subunit 2 (AP3S2) in Chicken. Korean J Poult Sci. 2019;46(1):31\u20137.","journal-title":"Korean J Poult Sci"},{"key":"4812_CR19","doi-asserted-by":"crossref","unstructured":"Resino S, Fern\u00e1ndez-Rodr\u00edguez A, Pineda-Tenor D, G\u00f3mez-Moreno AZ, S\u00e1nchez-Ruano JJ, Artaza-Varasa T et al. TRPM5 rs886277 Polymorphism Predicts Hepatic Fibrosis Progression in Non-Cirrhotic HCV-Infected Patients. J Clin Med. 2021;10(3).","DOI":"10.3390\/jcm10030483"},{"issue":"4","key":"4812_CR20","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jhep.2009.04.027","volume":"51","author":"Y Li","year":"2009","unstructured":"Li Y, Chang M, Abar O, Garcia V, Rowland C, Catanese J, et al. Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection. J Hepatol. 2009;51(4):750\u20137.","journal-title":"J Hepatol"},{"issue":"32","key":"4812_CR21","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.4254\/wjh.v8.i32.1354","volume":"8","author":"S Kiziltas","year":"2016","unstructured":"Kiziltas S. Toll-like receptors in pathophysiology of liver diseases. World J Hepatol. 2016;8(32):1354\u201369.","journal-title":"World J Hepatol"},{"key":"4812_CR22","doi-asserted-by":"crossref","unstructured":"Peng L-j, Guo J-s, Zhang Z, Liu L, Cao Y-r, Shi H et al. Polymorphisms of AZIN1 rs2679757 and TRPM5 rs886277 are Associated with Cirrhosis Risk in Chinese Patients with Chronic Hepatitis B. Infect Int. 2012;1.","DOI":"10.1515\/ii-2017-0016"},{"issue":"9","key":"4812_CR23","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1089\/gtmb.2013.0058","volume":"17","author":"L Peng","year":"2013","unstructured":"Peng L, Guo J, Zhang Z, Liu L, Cao Y, Shi H, et al. A candidate gene study for the association of host single nucleotide polymorphisms with liver cirrhosis risk in chinese hepatitis B patients. Genetic Test Mol biomarkers. 2013;17(9):681\u20136.","journal-title":"Genetic Test Mol biomarkers"},{"key":"4812_CR24","doi-asserted-by":"crossref","unstructured":"Noda Y, Sasaki S. Updates and Perspectives on Aquaporin-2 and Water Balance Disorders. Int J Mol Sci. 2021;22(23).","DOI":"10.3390\/ijms222312950"},{"key":"4812_CR25","doi-asserted-by":"publisher","first-page":"43446","DOI":"10.1038\/srep43446","volume":"7","author":"M Wang","year":"2017","unstructured":"Wang M, Gong Q, Zhang J, Chen L, Zhang Z, Lu L, et al. Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis. Sci Rep. 2017;7:43446.","journal-title":"Sci Rep"},{"key":"4812_CR26","volume-title":"Sampling Techniques,3rd Ed","author":"WG Cochran","year":"1977","unstructured":"Cochran WG. Sampling Techniques,3rd Ed. New York: John Wiley and Sons, Inc.; 1977."},{"issue":"36","key":"4812_CR27","doi-asserted-by":"publisher","first-page":"6025","DOI":"10.3748\/wjg.v27.i36.6025","volume":"27","author":"E Amponsah-Dacosta","year":"2021","unstructured":"Amponsah-Dacosta E. Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030? World J Gastroenterol. 2021;27(36):6025\u201338.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"4812_CR28","doi-asserted-by":"publisher","first-page":"116331","DOI":"10.1016\/j.diagmicrobio.2024.116331","volume":"109","author":"GM Salum","year":"2024","unstructured":"Salum GM, Abd El Meguid M, Fotouh BE, Abdel Aziz AO, Dawood RM. Comprehensive assessment of circulatory miRNAs as potential diagnostic markers in HCV recurrence post liver transplantation. Diagn Microbiol Infect Dis. 2024;109(3):116331.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4812_CR29","doi-asserted-by":"publisher","first-page":"156714","DOI":"10.1016\/j.cyto.2024.156714","volume":"182","author":"MA El-Meguid","year":"2024","unstructured":"El-Meguid MA, Lotaif LM, Salum GM, Fotouh BE, Salama RM, Salem M, et al. Evaluation of the expression of fibrosis-related genes as non-invasive diagnostic biomarkers for cirrhotic HCV-infected patients. Cytokine. 2024;182:156714.","journal-title":"Cytokine"},{"key":"4812_CR30","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ijid.2020.04.079","volume":"96","author":"M Rybicka","year":"2020","unstructured":"Rybicka M, Woziwodzka A, Sznarkowska A, Romanowski T, Stalke P, Dr\u0119czewski M, et al. Genetic variation in IL-10 influences the progression of hepatitis B infection. Int J Infect Dis. 2020;96:260\u20135.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"4812_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.cyto.2015.02.015","volume":"73","author":"VK Karra","year":"2015","unstructured":"Karra VK, Gumma PK, Chowdhury SJ, Ruttala R, Polipalli SK, Chakravarti A, et al. IL-18 polymorphisms in hepatitis B virus related liver disease. Cytokine. 2015;73(2):277\u201382.","journal-title":"Cytokine"},{"key":"4812_CR32","doi-asserted-by":"crossref","unstructured":"Xu MY, Qu Y, Li Z, Li F, Xiao CY, Lu LG. A 6 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis B. Frontiers in bioscience (Landmark edition). 2016;21(3):479\u201386.","DOI":"10.2741\/4403"},{"issue":"4","key":"4812_CR33","first-page":"222","volume":"2","author":"Y-J Wu","year":"2014","unstructured":"Wu Y-J, Xu M-Y, Lu L-G. Clinical Advances in Fibrosis Progression of Chronic Hepatitis B and C. J Clin Translational Hepatol. 2014;2(4):222\u20137.","journal-title":"J Clin Translational Hepatol"},{"issue":"1","key":"4812_CR34","doi-asserted-by":"publisher","first-page":"4913","DOI":"10.1038\/s41598-022-08955-x","volume":"12","author":"K Thanapirom","year":"2022","unstructured":"Thanapirom K, Suksawatamnuay S, Tanpowpong N, Chaopathomkul B, Sriphoosanaphan S, Thaimai P, et al. Non-invasive tests for liver fibrosis assessment in patients with chronic liver diseases: a prospective study. Sci Rep. 2022;12(1):4913.","journal-title":"Sci Rep"},{"issue":"12","key":"4812_CR35","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1097\/FPC.0b013e32834c3e74","volume":"21","author":"TM Curto","year":"2011","unstructured":"Curto TM, Lagier RJ, Lok AS, Everhart JE, Rowland CM, Sninsky JJ. Predicting cirrhosis and clinical outcomes in patients with advanced chronic hepatitis C with a panel of genetic markers (CRS7). Pharmacogenet Genomics. 2011;21(12):851\u201360.","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"4812_CR36","doi-asserted-by":"publisher","first-page":"20357","DOI":"10.1038\/s41598-022-24910-2","volume":"12","author":"N Yamamichi","year":"2022","unstructured":"Yamamichi N, Shimamoto T, Okushin K, Nishikawa T, Matsuzaki H, Yakabi S, et al. Fibrosis-4 index efficiently predicts chronic hepatitis and liver cirrhosis development based on a large-scale data of general population in Japan. Sci Rep. 2022;12(1):20357.","journal-title":"Sci Rep"},{"key":"4812_CR37","doi-asserted-by":"crossref","unstructured":"Afdhal NH, Bacon BR, Patel K, Lawitz EJ, Gordon SC, Nelson DR, et al. Accuracy of fibroscan, compared with histology, in analysis of liver fibrosis in patients with hepatitis B or C: a United States multicenter study. Clin Gastroenterol hepatology: official Clin Pract J Am Gastroenterological Association. 2015;13(4):772\u20139. e1-3.","DOI":"10.1016\/j.cgh.2014.12.014"},{"key":"4812_CR38","doi-asserted-by":"crossref","unstructured":"Ballestri S, Mantovani A, Baldelli E, Lugari S, Maurantonio M, Nascimbeni F et al. Liver Fibrosis Biomarkers Accurately Exclude Advanced Fibrosis and Are Associated with Higher Cardiovascular Risk Scores in Patients with NAFLD or Viral Chronic Liver Disease. Diagnostics (Basel, Switzerland). 2021;11(1).","DOI":"10.3390\/diagnostics11010098"},{"issue":"8","key":"4812_CR39","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1073\/pnas.0308700100","volume":"101","author":"O Yizhar","year":"2004","unstructured":"Yizhar O, Matti U, Melamed R, Hagalili Y, Bruns D, Rettig J, et al. Tomosyn inhibits priming of large dense-core vesicles in a calcium-dependent manner. Proc Natl Acad Sci. 2004;101(8):2578\u201383.","journal-title":"Proc Natl Acad Sci"},{"key":"4812_CR40","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jhep.2009.04.027","volume":"51","author":"Y Li","year":"2009","unstructured":"Li Y, Chang M, Abar O, Garcia V, Rowland C, Catanese J, et al. Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection. J Hepatol. 2009;51:750\u20137.","journal-title":"J Hepatol"},{"issue":"6","key":"4812_CR41","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.3892\/etm.2021.10824","volume":"22","author":"Y Qiu","year":"2021","unstructured":"Qiu Y, Xing Z, Guo Z, Liu Z. Upregulation of AQP2 mediated by transcription factor FOXO1 inhibits TGF-\u03b2-induced fibrosis in human urothelial cells. Exp Ther Med. 2021;22(6):1388.","journal-title":"Exp Ther Med"},{"issue":"1","key":"4812_CR42","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12964-023-01459-9","volume":"22","author":"A Bhattacharjee","year":"2024","unstructured":"Bhattacharjee A, Jana A, Bhattacharjee S, Mitra S, De S, Alghamdi BS, et al. The role of Aquaporins in tumorigenesis: implications for therapeutic development. Cell Communication Signal. 2024;22(1):106.","journal-title":"Cell Communication Signal"},{"issue":"4","key":"4812_CR43","first-page":"31","volume":"4","author":"W Nan","year":"2024","unstructured":"Nan W, Meiyi S, Fan Z, Sayed Obaidullah A, Phillip BH, Huiping Z. Dysregulation of sphingolipid metabolism in liver fibrosis. Metabolism Target Organ Damage. 2024;4(4):31.","journal-title":"Metabolism Target Organ Damage"},{"issue":"5","key":"4812_CR44","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1111\/hepr.13625","volume":"51","author":"K Miura","year":"2021","unstructured":"Miura K, Nagahashi M, Prasoon P, Hirose Y, Kobayashi T, Sakata J, et al. Dysregulation of sphingolipid metabolic enzymes leads to high levels of sphingosine-1-phosphate and ceramide in human hepatocellular carcinoma. Hepatol Res. 2021;51(5):614\u201326.","journal-title":"Hepatol Res"},{"issue":"10","key":"4812_CR45","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1172\/JCI71245","volume":"124","author":"Q Zhu","year":"2014","unstructured":"Zhu Q, Yamakuchi M, Ture S, de la Luz Garcia-Hernandez M, Ko KA, Modjeski KL, et al. Syntaxin-binding protein STXBP5 inhibits endothelial exocytosis and promotes platelet secretion. J Clin Investig. 2014;124(10):4503\u201316.","journal-title":"J Clin Investig"},{"key":"4812_CR46","doi-asserted-by":"publisher","first-page":"119590","DOI":"10.1016\/j.lfs.2021.119590","volume":"278","author":"J Wang","year":"2021","unstructured":"Wang J, Yang L, Li Y, Wang X-B, Yang W, Liu F, et al. Aberrant hypermethylation induced downregulation of antisense lncRNA STXBP5-AS1 and its sense gene STXBP5 correlate with tumorigenesis of glioma. Life Sci. 2021;278:119590.","journal-title":"Life Sci"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04812-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04812-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04812-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:44:49Z","timestamp":1780292689000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04812-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4812"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04812-7","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research conducted at the National Research Center, Cairo, Egypt, was approved by the Medical Research Ethics Committee under protocol number 12410123, adhering to the guidelines of the Helsinki Declaration. Before blood collection, all eligible participants signed an informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The study does not contain any identifiable individual data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"332"}}